Bas van der Baan
2023
In 2023, Bas van der Baan earned a total compensation of $66.6K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 61% decrease compared to previous year.
Compensation breakdown
| Option Awards | $48,131 |
|---|---|
| Other | $18,478 |
| Total | $66,609 |
der Baan received $48.1K in option awards, accounting for 72% of the total pay in 2023.
der Baan also received $18.5K in other compensation.
Rankings
In 2023, Bas van der Baan's compensation ranked 2,748th out of 2,804 executives tracked by ExecPay. In other words, der Baan earned more than 2.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,748 out of 2,804 | 2nd |
Division Manufacturing | 1,522 out of 1,541 | 1st |
Major group Chemicals And Allied Products | 861 out of 871 | 1st |
Industry group Drugs | 825 out of 834 | 1st |
Industry Pharmaceutical Preparations | 592 out of 599 | 1st |
Source: SEC filing on November 4, 2024.
der Baan's colleagues
We found four more compensation records of executives who worked with Bas van der Baan at LIXTE BIOTECHNOLOGY HOLDINGS in 2023.